Vertigo Treatment Market: Industry Analysis and Forecast 2030

Vertigo Treatment Market – Global Market Size, Strategic Growth Drivers, Risk Assessment Framework, Regulatory Landscape Review, Competitive Intensity Mapping & Long-Term Industry Outlook to 2030

4.63%

CAGR (2024-2030)

1.68 USD Bn.

Market Size

318

Report Pages

127

Market Tables

Overview

The Vertigo Treatment Market size was valued at USD 1.68 Billion in 2023 and the total Vertigo Treatment revenue is expected to grow at a CAGR of 4.63% from 2024 to 2030, reaching nearly USD 2.31 Billion by 2030.

Vertigo Treatment Market Overview

Vertigo is a condition causing loss of balance and spinning sensations even when not moving. Common causes include head injury, benign paroxysmal positional vertigo, vestibular neuronitis, Meniere's disease, and certain medications like cisplatin. Symptoms include nausea, vomiting, loss of balance, tinnitus, motion sickness, headaches, and difficulty in focusing. Treatments include steroids and water pills to reduce inflammation and fluid build-up in the ear. The global vertigo treatment market is growing because of an increase in vertigo conditions among adults and the aged, a rising geriatric population, increased awareness about inner ear problems, and availability of treatments. Low cost of medications and availability of OTC medications are also factors contributing to market growth. Public and private companies' initiatives and product launches are expected to drive market growth. The increasing number of clearances and product launches by key players in the market is a promising factor for the vertigo treatment market in the upcoming years.To know about the Research Methodology :- Request Free Sample Report

Vertigo Treatment Market Dynamics

The growing demand for vertigo treatment is driving the market growth in the forecast period.

The Vertigo Treatment market is growing because of the increasing incidence of vertigo, a symptom linked to various underlying conditions like inner ear issues, migraines, and neurological issues. As awareness of vertigo increases, there is a growing demand for effective treatment options. Advanced diagnostic equipment, such as vestibular testing and imaging strategies, are contributing to more accurate diagnoses of vertigo causes, bringing the market closer to personalize and focused healing methods. Device-based therapies, such as vestibular implants and neuromodulator devices, are emerging in the market to modulate vestibular function and offer solutions for specific vertigo situations. Telehealth services are becoming more universal, allowing for remote consultations, tracking, and follow-ups, enhancing accessibility to specialized care. Lifestyle and nutritional adjustments are also gaining popularity as complementary treatments for positive vertigo styles, including those related to Meniere's disease. Increased attention to vertigo and its treatment options is a significant trend.

• Vestibular rehabilitation training (VRT) is often beneficial for those with dizziness and balance issues. Most cases of vertigo are diagnosed and treated at the primary care level. Overuse of imaging procedures leads to direct healthcare costs. Liberatory maneuvers provide quick relief in BPPV treatment, the most common type in older adults.

Vertigo Treatment Market Restraints

The global vertigo treatment market faces challenges because of patients' ignorance of vertigo symptoms and causes, limited access to healthcare facilities, rising treatment costs, lack of access to anti-vertigo drugs, and inadequate standard tools for diagnosis and treatment. Side effects of medicines used in treating vertigo conditions, such as Antivert, which prevents motion sickness symptoms like nausea, vomiting, and dizziness, make patients sleepy or slow their breathing if interacting with alcohol or other drugs. Other side effects include blurred vision, dry mouth, constipation, dizziness, drowsiness, headache, vomiting, or tiredness, further restraining the growth of the vertigo treatment market.

Vertigo Treatment market is growing because of opportunities for investments in healthcare and rapid technological advancements. Vertigo is a movement sensation caused by disorders of the inner ear balance organs and their central connections. Treatment is only effective after a correct diagnosis of the underlying vestibular disorder. Advances in artificial intelligence offer novel strategies for diagnosing and treating this common symptom. Machine learning techniques are used to visualize, understand, and classify clinical data, creating a computerized, faster, and more accurate evaluation of vertiginous disorders. Practitioners also use these techniques as teaching tools to gain knowledge and valuable insights from medical data. This provides a better understanding of the work done thus far and future directions for research into the use of machine learning in vertigo diagnosis.

Vertigo Treatment Market Segment Analysis

Based on Treatment Type, Medications are expected to account for the highest market share of the global vertigo treatment market. A lot of people choose medicine over other types of treatment because it is often completed quickly. The global proliferation of vertigo medication and drug varieties is contributing to the growth of the market. Medication for vertigo also aid in treating patients' nausea and dizziness, which are side effects of vertigo.
The need for surgery vertigo therapy, meantime, is expected to increase steadily over the upcoming years. The market is growing because of part to rising awareness of vertigo and the availability of various surgical therapies for the condition. For the treatment of persistent and intractable vertigo, labyrinthectomy is one of the most commonly used surgery procedures. Over the next several years, the market is going to grow because of the increasing accessibility of less invasive surgical techniques for vertigo.

Vertigo Treatment Market Regional Insights

North American vertigo treatment market is dominated in 2023, the main factor driving the demand for vertigo treatments in this region is the increasing prevalence of vertigo among the aging population. The high number of various vertigo medications and therapies in this area is also a result of the existence of significant pharmaceutical businesses. It is expected that in the future, the United States and Canada are share the top spots in this area for suppliers of vertigo therapy. Compared to males, women in this area are more prone to experiencing vertigo. It is also expected that rising government funding and expenditures in medical research are encourage innovation in the vertigo treatment industry and drive future market growth.

Vertigo Treatment Market Competitive Landscapes

• April 16, 2024, Amneal Pharmaceuticals, Inc. announced the launch of PEMRYDI RTU®, the first and only ready-to-use presentation of pemetrexed for injection. This product does not require reconstitution, dilution, or refrigeration, which is different than other versions of pemetrexed for injection.

• April 22, 2024, Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for EMBLAVEO (aztreonam-avibactam) for the treatment of adult patients with complicated intra-abdominal infections (cIAI), hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP), and complicated urinary tract infections (cUTI), including pyelonephritis. It is also indicated for the treatment of infections because of aerobic Gram-negative organisms in adult patients with limited treatment options.

• On May 20, 2024, ANI Pharmaceuticals, Inc. announced the launch of Kionex (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use. Kionex Suspension is the only commercially available therapeutically equivalent to the reference listed drug (RLD) SPS® Suspension for Oral or Rectal use.

Vertigo Treatment Market Scope: Inquiry Before Buying

Vertigo Treatment Market
Report Coverage	Details
Base Year:	2023	Forecast Period:	2024-2030
Historical Data:	2018 to 2023	Market Size in 2023:	US $ 1.68 Bn.
Forecast Period 2024 to 2030 CAGR:	4.63%	Market Size in 2030:	US $ 2.31 Bn.
Segments Covered:	by Type	Peripheral Vertigo Central Vertigo
	by Treatment Type	Medication Surgery
	by End User	Hospitals Clinics Other

Vertigo Treatment Market by Region:

North America (United States, Canada, and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, and the Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria, and the Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Vertigo Treatment Market Key Players:

Vertigo Treatment Market in North America
1. AdvaCare Pharma (United States)
2. WellSpring Pharmaceutical Corporation (United States)
3. Mylan N.V. (United States)
4. Amneal Pharmaceuticals LLC (United States)
5. Prestige Consumer Healthcare Inc. (United States)
6. Casper Pharma (United States)
7. Epic Pharma, LLC (United States)
8. Sagent Pharmaceuticals (United States)
9. Pfizer Inc. (United States)
10. ANI Pharmaceuticals (United States)
11. Endo Pharmaceuticals Inc (United States)
12. Viatris Inc. (United States)
13. Sound Pharmaceuticals (United States)

Vertigo Treatment Market in Europe
1. Hoffmann-La Roche (Switzerland)
2. Medichem S.A. (Spain)
3. Sanofi (France)
4. GlaxoSmithKline (United Kingdom)

Vertigo Treatment Market in Asia Pacific
1. Zydus Cadila (India)
2. Sun Pharmaceutical Industries Ltd (India)
3. Intas Pharmaceutical Ltd. (India)

FAQs:

1. What are the growth drivers for the Vertigo Treatment Market?
Ans. Increasing Health Concerns and strict regulations are the major growth drivers for the Vertigo Treatment Market.

2. What are the major opportunities for the Vertigo Treatment Market growth?
Ans. Vertigo market is growing because of opportunities for investments in healthcare and rapid technological advancements.

3. Which region is expected to lead the global Vertigo Treatment Market during the forecast period?
Ans. North America is expected to lead the global Vertigo Treatment Market during the forecast period.

4. What is the projected market size & and growth rate of the Vertigo Treatment Market?
Ans. The Vertigo Treatment Market size was valued at USD 1.68 Billion in 2023 and the total Heavy Metal Testing revenue is expected to grow at a CAGR of 4.63% from 2024 to 2030, reaching nearly USD 2.31 Billion by 2030.

5. What segments are covered in the Vertigo Treatment Market report?
Ans. The segments covered in the Vertigo Treatment Market report are Type, Treatment Type, End User and Region.

1. Vertigo Treatment Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Vertigo Treatment Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Business Segment 2.3.3. End-user Segment 2.3.4. Revenue (2023) 2.3.5. Company Locations 2.4. Vertigo Treatment Market Companies, share% 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 3. Vertigo Treatment Market: Dynamics 3.1. Vertigo Treatment Market Trends 3.2. Vertigo Treatment Market Dynamics 3.2.1. Vertigo Treatment Market Drivers 3.2.2. Vertigo Treatment Market Restraints 3.2.3. Vertigo Treatment Market Opportunities 3.2.4. Vertigo Treatment Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape 3.7. Key Opinion Leader Analysis for Cardiac Biomarkers Industry 3.8. Analysis of Government Schemes and Initiatives for Cardiac Biomarkers Industry 3.9. Vertigo Treatment Market Trade Analysis 3.10. The Global Pandemic Impact on Vertigo Treatment Market 4. Vertigo Treatment Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 4.1. Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 4.1.1. Peripheral Vertigo 4.1.2. Central Vertigo 4.2. Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 4.2.1. Medication 4.2.2. Surgery 4.3. Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 4.3.1. Hospitals 4.3.2. Clinics 4.3.3. Other 4.4. Vertigo Treatment Market Size and Forecast, by Region (2023-2030) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Vertigo Treatment Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 5.1. North America Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 5.1.1. Peripheral Vertigo 5.1.2. Central Vertigo 5.2. North America Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 5.2.1. Medication 5.2.2. Surgery 5.3. Others North America Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 5.3.1. Hospitals 5.3.2. Clinics 5.3.3. Other 5.4. North America Vertigo Treatment Market Size and Forecast, by Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Vertigo Treatment Market Size and Forecast, By Type(2023-2030) 5.4.1.1.1. Peripheral Vertigo 5.4.1.1.2. Central Vertigo 5.4.1.2. United States Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 5.4.1.2.1. Medication 5.4.1.2.2. Surgery 5.4.1.3. United States Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 5.4.1.3.1. Hospitals 5.4.1.3.2. Clinics 5.4.1.3.3. Other 5.4.2. Canada 5.4.2.1. Canada Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 5.4.2.1.1. Peripheral Vertigo 5.4.2.1.2. Central Vertigo 5.4.2.2. Canada Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 5.4.2.2.1. Medication 5.4.2.2.2. Surgery 5.4.2.3. Canada Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 5.4.2.3.1. Hospitals 5.4.2.3.2. Clinics 5.4.2.3.3. Other 5.4.3. Mexico 5.4.3.1. Mexico Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 5.4.3.1.1. Peripheral Vertigo 5.4.3.1.2. Central Vertigo 5.4.3.2. Mexico Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 5.4.3.2.1. Medication 5.4.3.2.2. Surgery 5.4.3.3. Mexico Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 5.4.3.3.1. Hospitals 5.4.3.3.2. Clinics 5.4.3.3.3. Other 6. Europe Vertigo Treatment Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 6.1. Europe Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 6.2. Europe Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 6.3. Europe Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 6.4. Europe Vertigo Treatment Market Size and Forecast, by Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 6.4.1.2. United Kingdom Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 6.4.1.3. United Kingdom Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 6.4.2. France 6.4.2.1. France Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 6.4.2.2. France Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 6.4.2.3. France Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 6.4.3. Germany 6.4.3.1. Germany Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 6.4.3.2. Germany Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 6.4.3.3. Germany Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 6.4.4. Italy 6.4.4.1. Italy Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 6.4.4.2. Italy Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 6.4.4.3. Italy Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 6.4.5. Spain 6.4.5.1. Spain Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 6.4.5.2. Spain Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 6.4.5.3. Spain Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 6.4.6.2. Sweden Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 6.4.6.3. Sweden Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 6.4.7. Russia 6.4.7.1. Russia Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 6.4.7.2. Russia Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 6.4.7.3. Russia Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 6.4.8.2. Rest of Europe Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 6.4.8.3. Rest of Europe Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 7. Asia Pacific Vertigo Treatment Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 7.1. Asia Pacific Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 7.2. Asia Pacific Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 7.3. Asia Pacific Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 7.4. Asia Pacific Vertigo Treatment Market Size and Forecast, by Country (2023-2030) 7.4.1. China 7.4.1.1. China Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 7.4.1.2. China Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 7.4.1.3. China Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 7.4.2. S Korea 7.4.2.1. S Korea Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 7.4.2.2. S Korea Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 7.4.2.3. S Korea Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 7.4.3. Japan 7.4.3.1. Japan Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 7.4.3.2. Japan Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 7.4.3.3. Japan Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 7.4.4. India 7.4.4.1. India Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 7.4.4.2. India Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 7.4.4.3. India Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 7.4.5. Australia 7.4.5.1. Australia Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 7.4.5.2. Australia Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 7.4.5.3. Australia Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 7.4.6. ASEAN 7.4.6.1. ASEAN Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 7.4.6.2. ASEAN Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 7.4.6.3. ASEAN Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 7.4.7. Rest of Asia Pacific 7.4.7.1. Rest of Asia Pacific Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 7.4.7.2. Rest of Asia Pacific Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 7.4.7.3. Rest of Asia Pacific Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 8. Middle East and Africa Vertigo Treatment Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 8.1. Middle East and Africa Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 8.2. Middle East and Africa Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 8.3. Middle East and Africa Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 8.4. Middle East and Africa Vertigo Treatment Market Size and Forecast, by Country (2023-2030) 8.4.1. South Africa 8.4.1.1. South Africa Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 8.4.1.2. South Africa Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 8.4.1.3. South Africa Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 8.4.2. GCC 8.4.2.1. GCC Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 8.4.2.2. GCC Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 8.4.2.3. GCC Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 8.4.3. Rest of ME&A 8.4.3.1. Rest of ME&A Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 8.4.3.2. Rest of ME&A Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 8.4.3.3. Rest of ME&A Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 9. South America Vertigo Treatment Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 9.1. South America Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 9.2. South America Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 9.3. South America Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 9.4. South America Vertigo Treatment Market Size and Forecast, by Country (2023-2030) 9.4.1. Brazil 9.4.1.1. Brazil Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 9.4.1.2. Brazil Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 9.4.1.3. Brazil Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 9.4.2. Argentina 9.4.2.1. Argentina Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 9.4.2.2. Argentina Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 9.4.2.3. Argentina Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Vertigo Treatment Market Size and Forecast, By Type (2023-2030) 9.4.3.2. Rest Of South America Vertigo Treatment Market Size and Forecast, By Treatment Type (2023-2030) 9.4.3.3. Rest Of South America Vertigo Treatment Market Size and Forecast, By End-Use (2023-2030) 10. Company Profile: Key Players 10.1. AdvaCare Pharma 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Recent Developments 10.2. GlaxoSmithKline 10.3. WellSpring Pharmaceutical Corporation 10.4. Mylan N.V. 10.5. Amneal Pharmaceuticals LLC 10.6. Prestige Consumer Healthcare Inc. 10.7. Casper Pharma 10.8. Epic Pharma, LLC 10.9. Sagent Pharmaceuticals 10.10. Pfizer Inc. 10.11. ANI Pharmaceuticals 10.12. Zydus Cadila, 10.13. sun pharmaceutical industries ltd 10.14. Endo Pharmaceuticals Inc 10.15. Hoffmann-La Roche 10.16. Viatris Inc. 10.17. Intas Pharmaceutical Ltd. 10.18. Medichem S.A. 10.19. Sanofi 10.20. sound pharmaceuticals 11. Key Findings 12. Analyst Recommendations 13. Vertigo Treatment Market: Research Methodology

Vertigo Treatment Market

Choose License Type